WALL STREET ASSOCIATES - INTERSECT ENT INC ownership

INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 97 filers reported holding INTERSECT ENT INC in Q3 2016. The put-call ratio across all filers is 35.53 and the average weighting 0.1%.

Quarter-by-quarter ownership
WALL STREET ASSOCIATES ownership history of INTERSECT ENT INC
ValueSharesWeighting
Q3 2016$214,000
+22.3%
13,5000.0%0.07%
+4.3%
Q2 2016$175,000
-44.4%
13,500
-18.7%
0.07%
-46.6%
Q1 2016$315,000
-15.5%
16,6000.0%0.13%
+24.8%
Q4 2015$373,000
-3.9%
16,6000.0%0.10%
+41.9%
Q3 2015$388,000
-92.9%
16,600
-91.3%
0.07%
-85.6%
Q2 2015$5,468,000
+11.5%
191,000
+0.6%
0.52%
+11.2%
Q1 2015$4,905,000
+34.2%
189,900
-3.7%
0.46%
+31.9%
Q4 2014$3,656,000
+19.7%
197,1000.0%0.35%
+11.4%
Q3 2014$3,055,000197,1000.32%
Other shareholders
INTERSECT ENT INC shareholders Q3 2016
NameSharesValueWeighting ↓
KOPP INVESTMENT ADVISORS LLC 186,561$5,364,0004.51%
First Light Asset Management, LLC 517,121$14,867,0002.40%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,147,950$61,754,0002.21%
HealthCor Management, L.P. 1,950,000$56,063,0001.86%
PURA VIDA INVESTMENTS, LLC 200,000$5,750,0001.21%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 112,000$2,469,0001.17%
Broadfin Capital, LLC 234,200$6,733,0000.99%
Lombard Odier Asset Management (USA) Corp 240,000$6,900,0000.51%
PURA VIDA INVESTMENTS, LLC 83,527$2,401,0000.50%
Rock Springs Capital Management LP 460,000$13,225,0000.48%
View complete list of INTERSECT ENT INC shareholders